Healthcare has been a bedrock sector for private equity over the years. But things like headline risk and a difficult-to-predict regulatory environment are forcing many firms to rethink their strategies and move away from traditional subsectors in the space. Here’s where firms are spending more of their thesis development and deal sourcing time.
To read the entire story, you must be logged in.
Please log in now or register with us.
